Facts
The French Roller Skating Federation (Fédération Française de Roller Skating, FFRS) charges respondent M64 for a violation of the Anti-Doping Rules. During a contest on January 25, 2006, a sample was taken for doping test purposes. The analysis of the sample showed the presence of prednisolone and prednisone which are prohibited substances according the World Anti-Doping Agency (WADA) prohibited list.

History
The decision of the disciplinary committee of the FFRS was a period of ineligibility of four months from which three months conditionally. The respondent appealed against this decision and the appeal committee of the FFRS acquitted the charge.
The respondent had sent a copy of a prescription from his physician for medication containing glucocorticosteroids and copies of his medical file showing the results of his pulmonary function. The panel agrees that the medication is medical justifiable for his respiratory disease.

Decision
1. The decision of the appeal committee will not be changed.
2. The present decision will not be published.
3. The decision will be sent to the parties involved.

Facts
The French Federation of American Football (Fédération Française de Football Américain, FFFA) charges respondent M63 for a violation of the Anti-Doping Rules. During a match on March 25, 2006, respondent provided a sample for doping control. Analysis of the sample showed the presence of a metabolite of cannabis. Cannabis is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent admits the use but claims it wasn't used to enhance his sport performance.

Decision
1. The sanction is a period of ineligibility of three months in which respondent can't take part in competition or manifestations organized or authorized by the FFFA.
2. The decision starts on the date of notification.
3. The decision will be published and sent to the parties involved.

The Agenţia Naţională Anti-Doping (ANAD), the National Anti-Doping Agency of Romania, has reported an anti-doping rule violation against the Athlete Sebastian Mirel Varga after his sample tested positive for the prohibited substance stanozolol.
Therefore on 9 October 2006 the ANAD Sanction Committee decides to impose a 2 year period of ineligibility on the Athlete, starting on the date of the sample collection, i.e. on 9 September 2006.

Doping beim Freizeit- und Breitensport / Carl Müller-Platz, Carsten Boos, R. Klaus Müller

• Berlin : Robert Koch-Institut; Bonn : Statistisches Bundesamt, 2006
• Gesundheitsberichterstattung des Bundes, Heft 34
• ISBN 978-3-89606-174-4
• ISSN 1437-5478

Recreational sports in clubs and commercial sports
facilities are widespread in Germany. The positive health
effects are well documented. Unfortunately doping and
drug abuse also exist in this area. The few available
studies in Europe regarding doping beyond high level
sports point out that only a small number of customers
of fitness clubs abuses doping substances, males more
often than females. In particular among bodybuilders
there are users of prohibited substances (especially anabolic
steroids). The health-threatening potential of these
substances is considerable. Numerous biomedical side
effects including an increased mortality rate have been
documented.

Besides individual motives, like body-shaping also social
factors are of importance, when asking for the causes
of substance abuse in recreational sports. The often
careless use of substances for compensating alleged or
transient physical or mental disturbances is widespread
in our society. In order to be successful, prevention
measures should not be limited to the context of sports
alone. Moreover it is essential to create critical awareness
concerning performance enhancing substances in
all areas of daily life.

Effects of Hemopure on maximal oxygen uptake and endurance performance in healthy humans / M.J. Ashenden, Y. O. Schumacher, K. Sharpe, E. Varlet-Marie, M. Audran. - (International Journal of Sports Medicine 28 (2007) 5 (May); p. 381-385)

• PMID: 17024639
• DOI: 10.1055/s-2006-924365

Abstract

Haemoglobin-based oxygen carriers (HBOCs) such as Hemopure are touted as a tenable substitute for red blood cells and therefore potential doping agents, although the mechanisms of oxygen transport of HBOCs are incompletely understood. We investigated whether infusion of Hemopure increased maximal oxygen uptake (V.O 2max) and endurance performance in healthy subjects. Twelve male subjects performed two 4-minute submaximal exercise bouts equivalent to 60 % and 75 % of V.O (2max) on a cycle ergometer, followed by a ramped incremental protocol to elicit V.O (2max). A crossover design tested the effect of infusing either 30 g (6 subjects) or 45 g (6 subjects) of Hemopure versus a placebo. Under our study conditions, Hemopure did not increase V.O (2max) nor endurance performance. However, the infusion of Hemopure caused a decrease in heart rate of approximately 10 bpm (p=0.009) and an average increase in mean ( approximately 7 mmHg) and diastolic blood pressure ( approximately 8 mmHg) (p=0.046) at submaximal and maximal exercise intensities. Infusion of Hemopure did not bestow the same physiological advantages generally associated with infusion of red blood cells. It is conceivable that under exercise conditions, the hypertensive effects of Hemopure counter the performance-enhancing effect of improved blood oxygen carrying capacity.

Facts
The Certificate attests to the presence of Stanozolol metabolites in the Athlete's sample. Stanozolol is a prohibited substance named in the 2006 WADA Prohibited List.

Decision
The Athlete's written explanation, dated and received August 17, 2006, acknowledges his use of the prohibited substance. This early admission by the Athlete is to his credit. In this circumstance, it is fair that the period of ineligibility should commence on August 17, 2006. The period of ineligibility is two years commencing August 17, 2006.

Costs:
No party made any submission regarding costs. Accordingly, each party shall bear its own costs of the hearing.

β2-Agonists at the Olympic Games / Kenneth D. Fitch. - Clinical Reviews in Allergy & Immunology
1-Oct-2006, Volume 31, Issue 2-3, pp 259-268

The different approaches that the International Olympic Committee (IOC) had adopted to β2-agonists and the implications for athletes are reviewed by a former Olympic team physician who later became a member of the Medical Commission of the IOC (IOC-MC). Steadily increasing knowledge of the effects of inhaled β2-agonists on health, is concerned with the fact that oral β2-agonists may be anabolic, and rapid increased use of inhaled β2-agonists by elite athletes has contributed to the changes to the IOC rules. Since 2001, the necessity for athletes to meet IOC criteria (i.e., that they have asthma and/or exercise-induced asthma [EIA]) has resulted in imporved management of athletes. The prevalence of β2-agonist use by athletes mirrors the known prevalence of asthma symptoms in each country, although athletes in endurance events have the highest prevalence. The age-of-onset of asthma/EIA in elite winter athletes may be atypical. Of the 193 athletes at the 2006 Winter Olympics who met the IOC's criteria, only 32.1% had childhood asthma and 48.7% of athletes reported onset at age 20 yr or older. These findings lead to speculation that years of intense endurance training may be a causative factor in bronchial hyper reactivity. The distinction between oral (prohibited in sports) and inhaled salbutamol is possible, but athletes must be warned that excessive use of inhaled salbutamol can lead to urinary concentrations similar to those observed after oral administration. This article provides justification that athletes should provide evidence of asthma or EIA before being permitted to use inhaled β2-agonists.

Results of the WADA monitoring program regarding substances which are not on the 2005 Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport. These substances are:
- Caffeine
- Pseudoephedrine
- Phenylpropanolamine
- Synephrine
- Phenylephrine
- Pipradrol
- Bupropion
- Morphine / Codeine

Facts
The Irish Sports Council (ISC) and the Irish Martial Art Committee (IMAC) alleges the Athlete IS-1516 (the Athlete) for a violation of the Anti-Doping Rules. The athlete violated the applicable requirements regarding athlete availability for out-of-competition testing, including an alleged failure to provide “whereabouts” information as required.

History
Due to domestic problems the athlete didn't receive any letters addressed to her. She admits her failures and stopped competing in her sport.

Decision
Considering the circumstances the Panel felt that a period of three months was appropriate. The Athlete had already served a provisional suspension of three months imposed by the IMAC. That provisional suspension expired previously in September 2006. The Panel was satisfied that it would not be appropriate to impose a new sanction on the Athlete.

Facts
The French Ski Federation (Fédération Française de Ski, FFS) charges respondent M62 with a violation of the Anti-Doping Rules. During a ski event on March 25, 2006, the respondent didn't attend the doping control.

History
The respondent denies to be informed about having a doping control. He had left the competition earlier because of stomach problems. He has proof of visiting a physician and a declaration for leaving the competition.

Decision
1. The earlier decision (an acquittal) dated June 26, 2006, of the disciplinary committee of the FFS will not be modified.
2. The decision will be published and sent to the parties involved.